已收录 268922 条政策
 政策提纲
  • 暂无提纲
Antiarrhythmic Plasma Concentrations of Pirmenol on Canine Ventricular Arrhythmias
[摘要] References(20)Cited-By(13)Using two-stage coronary ligation-, digitalis- and adrenaline-induced canine ventricular arrhythmias, antiarrhythmic effects of pirmenol were examined, and the minimum effective plasma concentration for each arrhythmia model was determined. Pirmenol suppressed all the arrhythmias, and the minimum effective plasma concentrations for arrhythmias induced by 24 hr coronary ligation, 48 hr coronary ligation, digitalis and adrenaline were 1.1±0.3 (by 3 mg/kg, i.v.), 1.1±0.3 (by 3 mg/kg, i.v.), 1.1±0.2 (by 3 mg/kg, i.v.) and 2.5±1.5 (by 3 mg/kg, i.v.) μg/ml, respectively (mean±S.D.M., n=6-7). The concentration for adrenaline-induced arrhythmia was significantly higher than those for the other types of arrhythmias. This pharmacological profile is similar to those of mexiletine, tocainide and cibenzoline. Since pirmenol had no deleterious effects on the blood pressure and sinus node activity, its clinical usefulness is expected.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药理学
[关键词]  [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文